Back to search
FDAFDA · Food and drugs·Recall number D-1045-2016

Dicloxacillin Sodium Capsules, USP 250mg, Rx Only, 100 Capsule Bottle, Manufactured in Austria by Sandoz Gmbh, Distributed by Sandoz Inc., Princeton, NJ 08540, Product of Spain, NDC 0781-2248-01

Published June 29, 2016 · Recall initiated: May 2, 2016

Summary

FDA records drug Class III recall D-1045-2016, published June 29, 2016 and initiated May 2, 2016. Recalling firm: Sandoz, Inc; Status: Terminated; Reported quantity: 78,606 bottles; Lot: Lot #s: EN3846, Exp 08/2016; FA4809, Exp 2/2017, FW3654 , Exp11/2017. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz, Inc
Distributor
Nationwide
Lot
Lot #s: EN3846, Exp 08/2016; FA4809, Exp 2/2017, FW3654 , Exp11/2017
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dicloxacillin Sodium Capsules, USP 250mg, Rx Only, 100 Capsule Bottle, Manufactured in Austria by Sandoz Gmbh, Distributed by Sandoz Inc., Princeton, NJ 08540, Product of Spain, NDC 0781-2248-01 recalled?

Yes. FDA published recall D-1045-2016 on June 29, 2016. Reported hazard: Failed Impurities/Degradation Specifications:Out of specification result for a known impurity obtained during testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter